Evidence map›Paper›PMID 36671048›Full record

ReviewAntioxidants (Basel, Switzerland)2023

The Therapeutic Alliance between Pomegranate and Health Emphasizing on Anticancer Properties.

Panagiota D Pantiora, Alexandros I Balaouras, Ioanna K Mina, Christoforos I Freris, Athanasios C Pappas, Georgios P Danezis, Evangelos Zoidis, Constantinos A Georgiou

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Pomegranate (Veterinary sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Panagiota D PantioraDepartment of Biotechnology, Agricultural University of Athens, 11855 Athens, Greece.ORCID 0000-0002-4675-0435
Alexandros I BalaourasDepartment of Biotechnology, Agricultural University of Athens, 11855 Athens, Greece.
Ioanna K MinaDepartment of Biotechnology, Agricultural University of Athens, 11855 Athens, Greece.
Christoforos I FrerisDepartment of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Athanasios C PappasLaboratory of Nutritional Physiology and Feeding, Department of Animal Science, Agricultural University of Athens, 11855 Athens, Greece.ORCID 0000-0002-9586-8106
Georgios P DanezisChemistry Laboratory, Department of Food Science and Human Nutrition, Agricultural University of Athens, 11855 Athens, Greece.ORCID 0000-0002-1213-9400
Evangelos ZoidisLaboratory of Nutritional Physiology and Feeding, Department of Animal Science, Agricultural University of Athens, 11855 Athens, Greece.ORCID 0000-0002-4141-7772
Constantinos A GeorgiouChemistry Laboratory, Department of Food Science and Human Nutrition, Agricultural University of Athens, 11855 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pomegranate is a fruit bearing-plant that is well known for its medicinal properties. Pomegranate is a good source of phenolic acids, tannins, and flavonoids. Pomegranate juice and by-products have attracted the scientific interest due to their potential health benefits. Currently, the medical community has showed great interest in exploiting pomegranate potential as a protective agent against several human diseases including cancer. This is demonstrated by the fact that there are more than 800 reports in the literature reporting pomegranate's anticancer properties. This review is an update on the research outcomes of pomegranate's potential against different types of human diseases, emphasizing on cancer. In addition, perspectives of potential applications of pomegranate, as a natural additive aiming to improve the quality of animal products, are discussed.

Indexed as

animalantioxidantcancerflavonoidshealthpolyphenolic compoundspomegranate

Identifiers

PMID36671048
PMCPMC9855163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.